TNFSF13 and Miyoshi myopathy: Schmidts et al. [57] proposed an optimized BCMA/TACI-targeted CAR design by utilizing the natural trimeric conformation of APRIL and hypothesizing this will lead to improved binding kinetics and, therefore, efficacy in MM.